Search Results - "Clark, Tanya"
-
1
A propensity score‐matched, real‐world comparison of ustekinumab vs vedolizumab as a second‐line treatment for Crohn’s disease. The Cross Pennine study II
Published in Alimentary pharmacology & therapeutics (01-04-2022)“…Summary Background The optimal choice of biological agents after failure of anti‐tumour‐necrosis‐factor‐(TNF)α agent in Crohn’s disease (CD) is yet to be…”
Get full text
Journal Article -
2
Likely Exacerbation of Psychological Disorders from Covid-19 Response
Published in Journal of primary care & community health (2021)“…Anxiety and fear felt by people around the world regarding the coronavirus pandemic is real and can be overwhelming, resulting in strong emotional reactions in…”
Get full text
Journal Article -
3
Impact on direct and indirect costs of switching patients with inflammatory bowel disease from intravenous to subcutaneous infliximab (CT-P13)
Published in BMJ open gastroenterology (01-02-2023)“…BackgroundWe aim to compare the real-life direct and indirect costs of switching patients from intravenous to subcutaneous (SC) CT-P13, an infliximab…”
Get full text
Journal Article -
4
Infliximab Therapeutic Drug Monitoring in Inflammatory Bowel Disease Virtual Biologics Clinic Leads to Durable Clinical Results
Published in Inflammatory intestinal diseases (01-09-2021)“…Background: Therapeutic drug monitoring (TDM) of infliximab (IFX) trough levels and anti-drug antibodies in conjunction with symptoms, disease history, and…”
Get full text
Journal Article -
5
A Laboratory School Comparison of Mixed Amphetamine Salts Extended Release (Adderall XR®) and Atomoxetine (Strattera®) in School-Aged Children With Attention Deficit/Hyperactivity Disorder
Published in Journal of attention disorders (01-08-2005)“…Mixed amphetamine salts extended release (MAS XR; Adderall XR®) and atomoxetine (Strattera®) were compared in children 6 to 12 years old with attention…”
Get full text
Journal Article -
6
Efficacy and tolerability of initiating, or switching to, infliximab biosimilar CT-P13 in inflammatory bowel disease (IBD): a large single-centre experience
Published in Scandinavian journal of gastroenterology (03-06-2018)“…Objectives: Recently, the infliximab biosimilar (CT-P13) received market authorisation for inflammatory bowel disease (IBD), allowing cost benefits when…”
Get full text
Journal Article -
7
Relationship of Body Mass Index to Clinical Outcomes after Infliximab Therapy in Patients with Crohn’s Disease
Published in Journal of Crohn's and colitis (01-10-2016)“…Background & Aims: There are conflicting data for the role of obesity in Crohn’s disease (CD) and the effect on long-term clinical outcomes is poorly studied…”
Get full text
Journal Article -
8
Understanding Emerging Adults’ Perspectives on Mental Health in Togo
Published in Emerging adulthood (Thousand Oaks, CA) (01-04-2024)“…Mental health worldwide is extremely important to address; unfortunately, many aspects of mental health are not visibly known or treated in the world…”
Get full text
Journal Article -
9
Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease
Published in Inflammatory bowel diseases (01-12-2017)“…Virtual biologics clinics are often used to review patients with inflammatory bowel disease receiving biological therapy, with decisions whether to continue,…”
Get full text
Journal Article -
10
-
11
Long-term Efficacy and Safety of Azathioprine in Ulcerative Colitis
Published in Journal of Crohn's and colitis (01-02-2015)“…Background and aims: Azathioprine (AZA) is an established treatment for ulcerative colitis (UC). However, controversy exists regarding its efficacy in inducing…”
Get full text
Journal Article -
12
Costs of adalimumab versus infliximab as first-line biological therapy for luminal Crohn's disease
Published in Journal of Crohn's and colitis (01-05-2014)“…Randomised controlled trials demonstrate that the anti-tumour necrosis factor-α (anti-TNFα) therapies infliximab and adalimumab are effective in inducing…”
Get full text
Journal Article -
13
Quilting the race: Pauline Elizabeth Hopkins, the “Colored American Magazine”, and the African American family, 1900–1905
Published 01-01-2004“…The metaphor that structures my dissertation, “Quilting the Race: Pauline Elizabeth Hopkins, the Colored American Magazine, and the African American Family,…”
Get full text
Dissertation -
14
'Destructive' force: Toyota's Okuda speaks out
Published in Industry Week (06-07-1998)“…Toyota Motor Corp. is in trouble in its home market and in Asia. Only the booming American market and the ever-weakening yen are keeping the company…”
Get full text
Trade Publication Article -
15
JAPAN'S OTHER POWERHOUSE.(Brief Article)
Published in Industry Week (03-04-2000)“…Osaka, Japan has been named one of IndustryWeek's World-Class Communities. Osaka and Japan are 2 of the world's largest and most powerful manufacturing…”
Get full text
Magazine Article Trade Publication Article -
16
WIRED FOR PROGRESS.(Brief Article)
Published in Industry Week (03-04-2000)“…Tokyo, Japan, has been named one of IndustryWeek's World-Class Communities. The city's computer literati are jumping at the chance to bring new products and…”
Get full text
Magazine Article Trade Publication Article -
17
Teaching Mothers To Have Fun.(Hitachi's social-contribution program is a rarity in Japan)
Published in Industry Week (06-09-1999)“…Hitachi Ltd.'s Family Education Center at its Hitachi City company town in Japan was not designed for working women and their children. Rather, it was…”
Get full text
Magazine Article Trade Publication Article -
18
Restructuring, Japan-style
Published in Industry Week (17-08-1998)“…Widespread bankruptcies in Japan may bring the wholesale restructuring the Japanese economy needs in spite of itself, according to Japanese experts…”
Get full text
Magazine Article Trade Publication Article -
19
'DESTRUCTIVE'.(Toyota's president, Hiroshi Okuda)
Published in Industry week (06-07-1998)“…Toyota Pres Hiroshi Okuda sees time, patience and a willingness to diversify as keys to Honda's future success. Japan is suffering from a recession caused by a…”
Get full text
Magazine Article -
20
China's challenges
Published in Industry week (20-10-1997)“…In May 1997, Martin Posth, chairman and president of Volkswagen Asia-Pacific Ltd. and a member of the management board of Volkswagen AG, was wrapping up…”
Get full text
Magazine Article